Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 19 years or older who have been diagnosed with pancreatic or bile duct cancer that cannot be surgically removed, and whose doctor has planned for them to receive a specific combination chemotherapy treatment called nal-IRI/5-FU/LV
Who may not be able to join:
- People who do not agree to sign the consent form for the trial
- People who have previously had a severe drop in infection-fighting white blood cells (severe neutropenia) during chemotherapy treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sangmyung Woo, M.D, National Cancer Center
Phone: 82-31-920-1733
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.